Article in Current issues in molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 1 institution in 1 country.
Jin HanLaboratory for Arthritis and Cartilage Biology, Research Institute of Aging and Metabolism, Kyungpook National University, Daegu 41404, Republic of Korea.
Ju-Min YookDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
Se-Hyun OhCell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Yu Kyung ChungDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
Hee-Yeon JungDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.
Ji-Young ChoiDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.ORCID 0000-0002-9774-3665
Jang-Hee ChoCell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-7031-5214
Sun-Hee ParkDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.ORCID 0000-0002-0953-3343
Chan-Duck KimDivision of Nephrology, Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu 41944, Republic of Korea.ORCID 0000-0002-4648-0324
Yong-Lim KimCell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-1344-3455
Seungwoo HanLaboratory for Arthritis and Cartilage Biology, Research Institute of Aging and Metabolism, Kyungpook National University, Daegu 41404, Republic of Korea.ORCID 0000-0002-1614-7635
Jeong-Hoon LimCell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0001-5517-9886
Kyungpook National University Hospital · KR
Funding
Korea Health Industry Development Institute HR22C1832KOREAN NEPHROLOGY RESEARCH FOUNDATION FMC research fund 2023National Research Foundation of Korea 2021R1I1A3047973National Research Foundation of Korea RS-2023-00274788
6 · The paper itself
Abstract
Dual immunoglobulin domain-containing cell adhesion molecule (DICAM) is a type I transmembrane protein that presents in various cells including renal tubular cells. This study evaluated the expression and protective role of DICAM in renal tubular cell injury. HK-2 cells were incubated and treated with lipopolysaccharide (LPS, 30 μg/mL) or hydrogen peroxide (H
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Dual Immunoglobulin Domain-Containing Cell Adhesion Molecule Increases Early in Renal Tubular Cell Injury and Plays Anti-Inflammatory Role. · full record | OpenQuestion